174 related articles for article (PubMed ID: 1298588)
21. [A cytofluorometric study of the stability of secondary DNA structure in the epithelial cells in endometrial hyperplasia and cancer].
Ganina KP; Boĭko IuV
Tsitol Genet; 1996; 30(6):23-7. PubMed ID: 9139434
[TBL] [Abstract][Full Text] [Related]
22. Altered extent, pattern and characteristics of microvascular density are indicators of neoplastic progression in the endometrium.
Näyhä V; Viitanen T; Stenbäck F
Int J Cancer; 2005 Jul; 115(6):975-80. PubMed ID: 15723304
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and follow-up of atypical hyperplasia of corpus endometrium--a critical methodological investigation.
Geppert M; Smyczek-Gargya B; Menton M
Zentralbl Gynakol; 1993; 115(11):492-4. PubMed ID: 8296494
[TBL] [Abstract][Full Text] [Related]
24. [Characteristic of cystic glandular hyperplasia as a precursor of endometrial carcinoma].
Yokosuka K; Teshima H; Yamakawa Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1241-6. PubMed ID: 7844442
[TBL] [Abstract][Full Text] [Related]
25. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
Jovanovic AS; Boynton KA; Mutter GL
Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.
Punnonen R; Mattila J; Kuoppala T; Koivula T
J Cancer Res Clin Oncol; 1993; 119(7):426-9. PubMed ID: 8491764
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium.
Ito K; Sasano H; Yabuki N; Matsunaga G; Sato S; Kikuchi A; Yajima A; Nagura H
Mod Pathol; 1997 Apr; 10(4):289-94. PubMed ID: 9110289
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic aspects in endometrium dysplasias.
Florescu M; Simionescu C; Comănescu V; Plesea E
Rom J Morphol Embryol; 1996; 42(1-2):101-7. PubMed ID: 9038393
[TBL] [Abstract][Full Text] [Related]
29. The identification of stromal invasion in the distinction of atypical endometrial hyperplasia from well differentiated adenocarcinoma.
Kurman RJ
Verh Dtsch Ges Pathol; 1991; 75():371-2. PubMed ID: 1724844
[No Abstract] [Full Text] [Related]
30. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
31. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
33. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
McKenney JK; Longacre TA
Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy.
Nasir A; Boulware D; Kaiser HE; Lancaster JM; Coppola D; Smith PV; Hakam A; Siegel SE; Bodey B
In Vivo; 2007; 21(1):35-43. PubMed ID: 17354612
[TBL] [Abstract][Full Text] [Related]
35. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
36. [Endometrial hyperplasia and carcinoma in situ].
Ganchev S; Maĭnkhard K
Akush Ginekol (Sofiia); 1997; 36(3):47-50. PubMed ID: 9618961
[TBL] [Abstract][Full Text] [Related]
37. Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization.
Muslumanoglu HM; Oner U; Ozalp S; Acikalin MF; Yalcin OT; Ozdemir M; Artan S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):107-14. PubMed ID: 15866096
[TBL] [Abstract][Full Text] [Related]
38. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
[TBL] [Abstract][Full Text] [Related]
39. A comparative morphometric and cytophotometric study of endometrial hyperplasia, atypical hyperplasia, and endometrial carcinoma.
Norris HJ; Becker RL; Mikel UV
Hum Pathol; 1989 Mar; 20(3):219-23. PubMed ID: 2722172
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic histologic criteria of atypical adenomatous hyperplasia and well differentiated adenocarcinoma of the endometrium.
Liapis A; Pafitis A; Hassiakos D; Chirakis M; Zourlas PA
Eur J Gynaecol Oncol; 1994; 15(6):464-8. PubMed ID: 7875162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]